NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmalundensis AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
46
|
41
|
40 |
Earnings before taxes |
-397
|
-295
|
-255 |
EBITDA |
-258
|
-235
|
-215 |
Total assets |
988
|
787
|
812 |
Current assets |
252
|
56
|
111 |
Current liabilities |
239
|
213
|
91 |
Equity capital |
285
|
158
|
313 |
- share capital |
190
|
134
|
136 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
28.8%
|
20.1%
|
38.5% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-35.5%
|
-32.3%
|
-26.5% |
Current ratio |
105.4%
|
26.3%
|
122.0% |
Return on equity (ROE) |
-139.3%
|
-186.7%
|
-81.5% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.